fingolimod hydrochloride has been researched along with timolol in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (timolol) | Trials (timolol) | Recent Studies (post-2010) (timolol) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 3,932 | 1,198 | 805 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | timolol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0003 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.0026 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 0.452 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.712 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.712 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Georgakopoulos, CD; Georgalas, I; Makri, OE | 1 |
1 review(s) available for fingolimod hydrochloride and timolol
| Article | Year |
|---|---|
Drug-induced macular edema.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Fingolimod Hydrochloride; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Interferons; Macular Edema; Niacin; Ophthalmic Solutions; Propylene Glycols; Sphingosine; Tamoxifen; Taxoids; Thiazolidinediones; Timolol | 2013 |